Insider Buying: 3 Stocks Under $1
Low-priced names with real filings behind them
A low share price is not a bargain and it is not a thesis. What it does change is how much an insider's purchase says: at these levels a six-figure buy is a large personal position, not a rounding error on a bonus.
| Ticker | Price | Insiders | Bought | vs paid % |
|---|---|---|---|---|
| APCX | $0.15 | 2 | $116.1 million | -99.9% |
| GPUS | $0.16 | 4 | $6.42 million | -56.2% |
| OTLK | $0.57 | 2 | $2.60 million | -42.3% |
Latest updates
- October 7, 2026, 11:31 AM ET
This list has been rebuilt on the latest data. 3 names under $1, led by APCX at $116.1 million.
The dataTicker Price Insiders Bought vs paid % APCX $0.15 2 $116.1 million -99.9% GPUS $0.16 4 $6.42 million -56.2% OTLK $0.57 2 $2.60 million -42.3% Open-market purchases only (Form 4 code P).Source: SEC Form 4 filings · InsiderBuying.com - October 7, 2026, 11:00 AM ET
The screen was rerun and the list changed. 3 names under $1, led by APCX at $116.1 million.
- October 7, 2026, 10:26 AM ET
Refreshed: 3 names under $1, led by APCX at $116.1 million.
AppTech Payments Corp. (APCX)
Form 4 filings record 2 insiders buying $116.1 million of stock across 28 purchases, the most recent on September 3rd, 2026.
They paid an average of $223.22 a share, against a current 0.15 — -99.9% on what they paid. The largest single buyer on the filings is LORD ALBERT L.
Insider purchases are one of the few signals that cost the buyer money to send. It is not a forecast, and a purchase can be wrong; what it establishes is that someone with a statutory duty to disclose chose to take the position anyway.
Hyperscale Data, Inc. (GPUS)
According to the filings, 4 insiders buying $6.42 million of stock across 46 purchases, the most recent on September 30th, 2026.
They paid an average of $0.37 a share, against a current 0.16 — -56.2% on what they paid. The largest single buyer on the filings is AULT MILTON C III.
Insider purchases are one of the few signals that cost the buyer money to send. It is not a forecast, and a purchase can be wrong; what it establishes is that someone with a statutory duty to disclose chose to take the position anyway.
Outlook Therapeutics, Inc. (OTLK)
Disclosures on file show 2 insiders buying $2.60 million of stock across 2 purchases, the most recent on August 12th, 2026.
They paid an average of $0.99 a share, against a current 0.57 — -42.3% on what they paid. The largest single buyer on the filings is Sukhtian Ghiath M..
Insider purchases are one of the few signals that cost the buyer money to send. It is not a forecast, and a purchase can be wrong; what it establishes is that someone with a statutory duty to disclose chose to take the position anyway.
- APCX —
- GPUS —
- OTLK —
- APCX +0.0%
- GPUS +0.0%
- OTLK +0.0%
- APCX —
- GPUS —
- OTLK —
The bottom line
Cheap stocks are cheap for reasons the filings do not explain. Treat the purchase as a fact about the buyer, not a verdict on the business. Not investment advice. Summarized from public SEC Form 4 and congressional disclosure data.